Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Mowat

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
The Oncologist|April 21, 2022
Randomized Phase II Study of Two Doses of Pixantrone in Patients with Metastatic Breast Cancer (NCCTG N1031, Alliance)Kostandinos Sideras, David W Hillman, Karthik Giridhar, et al.
Pharmacoeconomics|August 27, 2014
Comparative economics of a 12-gene assay for predicting risk of recurrence in stage II colon cancerSteven R Alberts, Tiffany M Yu, Robert J Behrens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2015
Gene expression profiling identifies responsive patients with cancer of unknown primary treated with carboplatin, paclitaxel, and everolimus: NCCTG N0871 (alliance)H H Yoon, N R Foster, J P Meyers, et al.
Cancer|October 21, 2017
Expression of the DNA repair gene MLH1 correlates with survival in patients who have resected pancreatic cancer and have received adjuvant chemoradiation: NRG Oncology RTOG Study 9704Yaacov R Lawrence, Jennifer Moughan, Anthony M Magliocco, et al.
Clinical Colorectal Cancer|September 17, 2013
Impact of physical activity after cancer diagnosis on survival in patients with recurrent colon cancer: Findings from CALGB 89803/AllianceJustin Jeon, Kaori Sato, Donna Niedzwiecki, et al.
Journal of the National Cancer Institute|November 16, 2013
Predictive and prognostic analysis of PIK3CA mutation in stage III colon cancer intergroup trialShuji Ogino, Xiaoyun Liao, Yu Imamura, et al.
JAMA Oncology|May 1, 2018
Association of Survival With Adherence to the American Cancer Society Nutrition and Physical Activity Guidelines for Cancer Survivors After Colon Cancer Diagnosis: The CALGB 89803/Alliance TrialErin L Van Blarigan, Charles S Fuchs, Donna Niedzwiecki, et al.
Plos One|June 18, 2014
Sugar-sweetened beverage intake and cancer recurrence and survival in CALGB 89803 (Alliance)Michael A Fuchs, Kaori Sato, Donna Niedzwiecki, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 6, 2020
The Diet of Higher Insulinemic Potential Is Not Associated with Worse Survival in Patients with Stage III Colon Cancer (Alliance)En Cheng, Sui Zhang, Fang-Shu Ou, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 24, 2018
Marine ω-3 Polyunsaturated Fatty Acid and Fish Intake after Colon Cancer Diagnosis and Survival: CALGB 89803 (Alliance)Erin L Van Blarigan, Charles S Fuchs, Donna Niedzwiecki, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
The Oncologist|April 21, 2022
Randomized Phase II Study of Two Doses of Pixantrone in Patients with Metastatic Breast Cancer (NCCTG N1031, Alliance)Kostandinos Sideras, David W Hillman, Karthik Giridhar, et al.
Pharmacoeconomics|August 27, 2014
Comparative economics of a 12-gene assay for predicting risk of recurrence in stage II colon cancerSteven R Alberts, Tiffany M Yu, Robert J Behrens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2015
Gene expression profiling identifies responsive patients with cancer of unknown primary treated with carboplatin, paclitaxel, and everolimus: NCCTG N0871 (alliance)H H Yoon, N R Foster, J P Meyers, et al.
Cancer|October 21, 2017
Expression of the DNA repair gene MLH1 correlates with survival in patients who have resected pancreatic cancer and have received adjuvant chemoradiation: NRG Oncology RTOG Study 9704Yaacov R Lawrence, Jennifer Moughan, Anthony M Magliocco, et al.
Clinical Colorectal Cancer|September 17, 2013
Impact of physical activity after cancer diagnosis on survival in patients with recurrent colon cancer: Findings from CALGB 89803/AllianceJustin Jeon, Kaori Sato, Donna Niedzwiecki, et al.
Journal of the National Cancer Institute|November 16, 2013
Predictive and prognostic analysis of PIK3CA mutation in stage III colon cancer intergroup trialShuji Ogino, Xiaoyun Liao, Yu Imamura, et al.
JAMA Oncology|May 1, 2018
Association of Survival With Adherence to the American Cancer Society Nutrition and Physical Activity Guidelines for Cancer Survivors After Colon Cancer Diagnosis: The CALGB 89803/Alliance TrialErin L Van Blarigan, Charles S Fuchs, Donna Niedzwiecki, et al.
Plos One|June 18, 2014
Sugar-sweetened beverage intake and cancer recurrence and survival in CALGB 89803 (Alliance)Michael A Fuchs, Kaori Sato, Donna Niedzwiecki, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 6, 2020
The Diet of Higher Insulinemic Potential Is Not Associated with Worse Survival in Patients with Stage III Colon Cancer (Alliance)En Cheng, Sui Zhang, Fang-Shu Ou, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 24, 2018
Marine ω-3 Polyunsaturated Fatty Acid and Fish Intake after Colon Cancer Diagnosis and Survival: CALGB 89803 (Alliance)Erin L Van Blarigan, Charles S Fuchs, Donna Niedzwiecki, et al.
Pageof 3